Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lysine + Ferric Ammonium Citrate + Folic Acid + Vitamin Blends is a multi-ingredient nutraceutical supplement manufactured by Saltvae Pharmaceuticals. Formulated as oral liquid drops, it is primarily intended for pediatric use to support growth and prevent nutritional deficiencies. The combination includes L-lysine, an essential amino acid for protein synthesis; ferric ammonium citrate (FAC), which provides elemental iron for hemoglobin production; folic acid (vitamin B9), essential for erythropoiesis and DNA synthesis; and a blend of vitamins that act as metabolic cofactors. This product is marketed as a commercial generic dietary supplement in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lysine + Ferric Ammonium Citrate + Folic Acid + Vitamin Blends.